Effect of Calcium and Vitamin D on Bone Loss From the Hip

NCT00357643 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2006-07-27

No results posted yet for this study

Summary

The primary aim of this study is to determine the effects of supplementation with both calcium and vitamin D on changes in bone density of the hip in men and women age 65 and older.

Conditions

Interventions

DRUG

Calcium 500 mg/day and vitamin D 700 IU/day

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Tufts University

    lead OTHER

Principal Investigators

  • Bess Dawson-Hughes, MD · Tufts University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1992-10-31
Completion
1996-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00357643 on ClinicalTrials.gov